By expenditures
| Name | Title | Type |
|---|---|---|
| Brandi Claxton | Interim Secretary Of Treasury | Auditee |
| Jodi L. Dobson | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 384060 | 2024 | 2026-01-27 | BAKER TILLY US LLP | $104.73M |
| 343770 | 2023 | 2025-02-25 | Baker Tilly US LLP | $131.11M |
| 308719 | 2022 | 2024-06-12 | Baker Tilly US LLP | $91.75M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 384060 | 2024 | 2026-01-27 | 1170811 | 2024-005 | Material Weakness | Yes | L |
| 384060 | 2024 | 2026-01-27 | 1170810 | 2024-005 | Material Weakness | Yes | L |
| 384060 | 2024 | 2026-01-27 | 1170809 | 2024-005 | Material Weakness | Yes | L |
| 384060 | 2024 | 2026-01-27 | 1170808 | 2024-005 | Material Weakness | Yes | L |
| 384060 | 2024 | 2026-01-27 | 1170807 | 2024-005 | Material Weakness | Yes | L |
| 384060 | 2024 | 2026-01-27 | 1170806 | 2024-005 | Material Weakness | Yes | L |
| 384060 | 2024 | 2026-01-27 | 1170805 | 2024-004 | Material Weakness | Yes | M |
| 384060 | 2024 | 2026-01-27 | 1170804 | 2024-004 | Material Weakness | Yes | M |
| 384060 | 2024 | 2026-01-27 | 1170803 | 2024-004 | Material Weakness | Yes | M |
| 384060 | 2024 | 2026-01-27 | 1170802 | 2024-004 | Material Weakness | Yes | M |
| 384060 | 2024 | 2026-01-27 | 1170801 | 2024-004 | Material Weakness | Yes | M |
| 384060 | 2024 | 2026-01-27 | 1170800 | 2024-004 | Material Weakness | Yes | M |
| 384060 | 2024 | 2026-01-27 | 1170799 | 2024-002 | Material Weakness | Yes | N |
| 384060 | 2024 | 2026-01-27 | 1170798 | 2024-002 | Material Weakness | Yes | N |
| 384060 | 2024 | 2026-01-27 | 1170797 | 2024-002 | Material Weakness | Yes | N |
| 384060 | 2024 | 2026-01-27 | 1170796 | 2024-003 | Material Weakness | Yes | B |
| 343770 | 2023 | 2025-02-25 | 1100888 | 2023-002 | Significant Deficiency | - | N |
| 343770 | 2023 | 2025-02-25 | 1100887 | 2023-002 | Significant Deficiency | - | N |
| 343770 | 2023 | 2025-02-25 | 1100886 | 2023-002 | Significant Deficiency | - | N |
| 343770 | 2023 | 2025-02-25 | 1100885 | 2023-002 | Significant Deficiency | - | N |
| 343770 | 2023 | 2025-02-25 | 524446 | 2023-002 | Significant Deficiency | - | N |
| 343770 | 2023 | 2025-02-25 | 524445 | 2023-002 | Significant Deficiency | - | N |
| 343770 | 2023 | 2025-02-25 | 524444 | 2023-002 | Significant Deficiency | - | N |
| 343770 | 2023 | 2025-02-25 | 524443 | 2023-002 | Significant Deficiency | - | N |
| 308719 | 2022 | 2024-06-12 | 977110 | 2022-002 | Significant Deficiency | - | B |
| 308719 | 2022 | 2024-06-12 | 977109 | 2022-002 | Significant Deficiency | - | B |
| 308719 | 2022 | 2024-06-12 | 977108 | 2022-002 | Significant Deficiency | - | B |
| 308719 | 2022 | 2024-06-12 | 977107 | 2022-002 | Significant Deficiency | - | B |
| 308719 | 2022 | 2024-06-12 | 977106 | 2022-002 | Significant Deficiency | - | B |
| 308719 | 2022 | 2024-06-12 | 977105 | 2022-002 | Significant Deficiency | - | B |
| 308719 | 2022 | 2024-06-12 | 977104 | 2022-002 | Significant Deficiency | - | B |
| 308719 | 2022 | 2024-06-12 | 977103 | 2022-003 | Significant Deficiency | - | E |
| 308719 | 2022 | 2024-06-12 | 977102 | 2022-002 | Significant Deficiency | - | B |
| 308719 | 2022 | 2024-06-12 | 400668 | 2022-002 | Significant Deficiency | - | B |
| 308719 | 2022 | 2024-06-12 | 400667 | 2022-002 | Significant Deficiency | - | B |
| 308719 | 2022 | 2024-06-12 | 400666 | 2022-002 | Significant Deficiency | - | B |
| 308719 | 2022 | 2024-06-12 | 400665 | 2022-002 | Significant Deficiency | - | B |
| 308719 | 2022 | 2024-06-12 | 400664 | 2022-002 | Significant Deficiency | - | B |
| 308719 | 2022 | 2024-06-12 | 400663 | 2022-002 | Significant Deficiency | - | B |
| 308719 | 2022 | 2024-06-12 | 400662 | 2022-002 | Significant Deficiency | - | B |
| 308719 | 2022 | 2024-06-12 | 400661 | 2022-003 | Significant Deficiency | - | E |
| 308719 | 2022 | 2024-06-12 | 400660 | 2022-002 | Significant Deficiency | - | B |